DE60135393D1 - Allelische Variante des Interferon-ähnlichen Proteins Zcyto21 - Google Patents

Allelische Variante des Interferon-ähnlichen Proteins Zcyto21

Info

Publication number: DE60135393D1
Authority: DE; Germany
Prior art keywords: interferon; zcyto21; allelic variant; amino acid; protein
Prior art date: 2000-06-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60135393T

Other languages

English (en)

Inventor

Paul O Sheppard

Scott R Presnell

Brian A Fox

Teresa Gilbert

Betty A Haldeman

Francis J Grant

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Zymogenetics Inc

Original Assignee

Zymogenetics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-30

Filing date

2001-06-29

Publication date

2008-09-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26910034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60135393(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-06-29 Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc

2008-09-25 Application granted granted Critical

2008-09-25 Publication of DE60135393D1 publication Critical patent/DE60135393D1/de

2021-06-30 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

108090000623 proteins and genes Proteins 0.000 title abstract 4
102000004169 proteins and genes Human genes 0.000 title 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 2
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
125000000539 amino acid group Chemical group 0.000 abstract 1
238000011813 knockout mouse model Methods 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
238000011830 transgenic mouse model Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Psychiatry (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

DE60135393T 2000-06-30 2001-06-29 Allelische Variante des Interferon-ähnlichen Proteins Zcyto21 Expired - Lifetime DE60135393D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US21544600P	2000-06-30	2000-06-30
US28542401P	2001-04-20	2001-04-20

Publications (1)

Publication Number	Publication Date
DE60135393D1 true DE60135393D1 (de)	2008-09-25

Family

ID=26910034

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE60135393T Expired - Lifetime DE60135393D1 (de)	2000-06-30	2001-06-29	Allelische Variante des Interferon-ähnlichen Proteins Zcyto21
DE60128093T Expired - Lifetime DE60128093T2 (de)	2000-06-30	2001-06-29	Interferon-ähnliches protein zcyto21

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE60128093T Expired - Lifetime DE60128093T2 (de)	2000-06-30	2001-06-29	Interferon-ähnliches protein zcyto21

Country Status (13)

Country	Link
US (18)	US6927040B2 (de)
EP (4)	EP2132984A3 (de)
JP (1)	JP4377126B2 (de)
CN (1)	CN100448993C (de)
AT (2)	ATE360696T1 (de)
AU (1)	AU2001271786A1 (de)
BR (1)	BR0112119A (de)
CA (1)	CA2413258C (de)
DE (2)	DE60135393D1 (de)
DK (2)	DK1717316T3 (de)
ES (2)	ES2286128T3 (de)
RU (1)	RU2292394C2 (de)
WO (1)	WO2002002627A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6927040B2 (en) *	2000-06-30	2005-08-09	Zymogenetics, Inc.	Interferon-like protein Zcyto21
US7038032B2 (en) *	2001-04-20	2006-05-02	Zymogenetics, Inc.	Cytokine protein family
US7910313B2 (en)	2001-04-20	2011-03-22	Zymogenetics, Inc.	Cytokine protein family
JP2004535795A (ja) *	2001-05-10	2004-12-02	イミュネックス・コーポレーション	サイトカインポリペプチド群
WO2003029262A2 (en) *	2001-08-29	2003-04-10	Vanderbilt University	The human mob-5 (il-24) receptors and uses thereof
AU2003215136A1 (en)	2002-02-08	2003-09-02	University Of Medicine And Dentistry Of New Jersey	Ifn-a/b-independent mechanism of antiviral protection
EP1497415B1 (de)	2002-04-19	2010-12-29	ZymoGenetics, L.L.C.	Verfahren zum nachweis oder zur modulierung der wechselwirkung eines cytokinrezeptors mit seinem ligand
KR20050065519A (ko) *	2002-08-07	2005-06-29	델타 바이오테크놀로지 리미티드	알부민-융합 섬모 신경영양 인자
EP1575609A4 (de) *	2002-10-23	2010-12-15	Zymogenetics L L C	Verfahren zur behandlung von virusinfektionen unter verwendung von il-28 und il-29
WO2005023862A2 (en) *	2003-08-07	2005-03-17	Zymogenetics, Inc.	Homogeneous preparations of il-28 and il-29
US20050244423A1 (en)	2004-04-02	2005-11-03	Klucher Kevin M	Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
WO2006012644A2 (en) *	2004-07-29	2006-02-02	Zymogenetics, Inc.	Use of il-28 and il-29 to treat cancer
RU2389502C2 (ru) *	2004-07-29	2010-05-20	Займодженетикс, Инк.	Применение il-28 и il-29 для лечения карциномы и аутоиммунных нарушений
US20060178301A1 (en) *	2005-02-04	2006-08-10	Mathias Jurs	Albumin-fused ciliary neurotrophic factor
AU2006269908A1 (en) *	2005-07-20	2007-01-25	Bristol-Myers Squibb Company	IL28 and IL29 truncated cysteine mutants and antiviral methods of using same
JP4987001B2 (ja) *	2005-07-20	2012-07-25	ザイモジェネティクスリミテッドライアビリティカンパニー	癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法
WO2007041713A1 (en) *	2005-10-04	2007-04-12	Zymogenetics, Inc.	Production and purification of il-29
TW200744634A (en) *	2006-02-21	2007-12-16	Wyeth Corp	Methods of using antibodies against human IL-22
AU2008364115B2 (en)	2007-12-07	2013-11-21	Zymogenetics, Inc.	Anti-human IL-21 monoclonal antibodies
AU2009231598B2 (en)	2008-04-04	2015-03-12	The Trustees Of The University Of Pennsylvania	Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same
AU2009255994B2 (en) *	2008-06-05	2014-07-17	Bristol-Myers Squibb Company	Use of pegylated Type III Interferons for the treatment of hepatitis C
US20110263484A1 (en) *	2008-10-13	2011-10-27	Zymogenetics, Inc.	Single chain fc type iii interferons and methods of using same
EP2563720A1 (de)	2010-04-28	2013-03-06	Murata Manufacturing Co., Ltd.	Perowskitmaterial mit anionengesteuerten dielektrischen eigenschaften, dünnschichtkondensatorvorrichtung und herstellungsverfahren dafür
FR2975185A1 (fr) *	2011-05-12	2012-11-16	Univ Claude Bernard Lyon	Procede de determination in vitro de la presence d'une sclerose en plaques
RU2549710C2 (ru) *	2012-06-29	2015-04-27	Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства (ФГБУ "ГНЦ Институт иммунологии" ФМБА России)	Способ очистки рекомбинантного белка интерфероноподобного фактора iii типа
CN102998450B (zh) *	2012-11-22	2014-10-15	北京正旦国际科技有限责任公司	一种食管癌免疫质谱检测试剂盒的制备方法
CN109293782A (zh)	2014-01-08	2019-02-01	德益阳光生物技术（北京）有限责任公司	融合多肽及使用方法
US10076512B2 (en)	2014-05-01	2018-09-18	Eiger Biopharmaceuticals, Inc.	Treatment of hepatitis delta virus infection
US11311519B2 (en)	2014-05-01	2022-04-26	Eiger Biopharmaceuticals, Inc.	Treatment of hepatitis delta virus infection
DK3285768T3 (da)	2015-04-21	2021-01-25	Eiger Biopharmaceuticals Inc	Farmaceutiske sammensætninger omfattende lonafarnib og ritonavir
ES2874592T3 (es)	2016-02-19	2021-11-05	Eiger Biopharmaceuticals Inc	Tratamiento de la infección por el virus de la hepatitis delta con interferón lambda
JP2019531729A (ja) *	2016-09-30	2019-11-07	ザボードオブトラスティーズオブザレランドスタンフォードジュニアユニバーシティー	変異体ｉｉｉ型インターフェロン及びシンセカイン

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3000213A1 (de)	1980-01-04	1981-07-09	Zahnfabrik Wienand Söhne & Co GmbH, 6072 Dreieich	Verfahren zur herstellung eines vernetzten polymerisatz fuer dentalzwecke
DE3165463D1 (en) *	1980-01-08	1984-09-20	Biogen Nv	Dna sequences, recombinant dna molecules and processes for producing human interferon-alpha like polypeptides
DK368882A (da)	1981-08-25	1983-02-26	Alan John Kingsman	Expessions vektorer
US4579821A (en)	1981-11-23	1986-04-01	University Patents, Inc.	Control of DNA sequence transcription
US4656134A (en)	1982-01-11	1987-04-07	Board Of Trustees Of Leland Stanford Jr. University	Gene amplification in eukaryotic cells
US4486533A (en)	1982-09-02	1984-12-04	St. Louis University	Filamentous fungi functional replicating extrachromosomal element
US4599311A (en)	1982-08-13	1986-07-08	Kawasaki Glenn H	Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en)	1985-06-26	1990-12-11	Amgen	Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4601978A (en)	1982-11-24	1986-07-22	The Regents Of The University Of California	Mammalian metallothionein promoter system
US4713339A (en)	1983-01-19	1987-12-15	Genentech, Inc.	Polycistronic expression vector construction
US5139936A (en)	1983-02-28	1992-08-18	Collaborative Research, Inc.	Use of the GAL1 yeast promoter
US4661454A (en)	1983-02-28	1987-04-28	Collaborative Research, Inc.	GAL1 yeast promoter linked to non galactokinase gene
US4870008A (en)	1983-08-12	1989-09-26	Chiron Corporation	Secretory expression in eukaryotes
US4496778A (en) *	1983-10-03	1985-01-29	Exxon Research & Engineering Co.	Process for the hydroxylation of olefins using molecular oxygen, an osmium containing catalyst, a copper Co-catalyst, and an aromatic amine based promoter
US4931373A (en)	1984-05-25	1990-06-05	Zymogenetics, Inc.	Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en)	1985-02-25	1988-08-23	Zymogenetics Inc.	Expression of biologically active PDGF analogs in eucaryotic cells
CA1280080C (en)	1984-12-06	1991-02-12	Jacques Oberto	Promoters for the expression of foreign genes in yeast, plasmids comprising them, and uses thereof for the production of polypeptides
US4683202A (en)	1985-03-28	1987-07-28	Cetus Corporation	Process for amplifying nucleic acid sequences
GR860984B (en)	1985-04-17	1986-08-18	Zymogenetics Inc	Expression of factor vii and ix activities in mammalian cells
US4882279A (en)	1985-10-25	1989-11-21	Phillips Petroleum Company	Site selective genomic modification of yeast of the genus pichia
US4935349A (en)	1986-01-17	1990-06-19	Zymogenetics, Inc.	Expression of higher eucaryotic genes in aspergillus
GB8611832D0 (en)	1986-05-15	1986-06-25	Holland I B	Polypeptide
US4946778A (en) *	1987-09-21	1990-08-07	Genex Corporation	Single polypeptide chain binding molecules
US5063154A (en)	1987-06-24	1991-11-05	Whitehead Institute For Biomedical Research	Pheromone - inducible yeast promoter
US4956288A (en)	1988-04-22	1990-09-11	Biogen, Inc.	Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5037743A (en)	1988-08-05	1991-08-06	Zymogenetics, Inc.	BAR1 secretion signal
US5162228A (en)	1988-12-28	1992-11-10	Takeda Chemical Industries, Ltd.	Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5298418A (en)	1991-09-16	1994-03-29	Boyce Thompson Institute For Plant Research, Inc.	Cell line isolated from larval midgut tissue of Trichoplusia ni
US5565332A (en) *	1991-09-23	1996-10-15	Medical Research Council	Production of chimeric antibodies - a combinatorial approach
US5700638A (en) *	1993-08-26	1997-12-23	Washington University	Cell death regulator
US6451578B1 (en) *	1994-02-14	2002-09-17	Abbott Laboratories	Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
JPH09508797A (ja)	1994-02-14	1997-09-09	ザイモジェネティクス，インコーポレイティド	造血タンパク質及びそれを製造するための材料及び方法
US5641655A (en)	1994-11-30	1997-06-24	Zymogenetics, Inc.	Methods for producing thrombopoietin polypeptides using a mammalian tissue plasminogen activator secretory peptide
US5679715A (en) *	1995-06-07	1997-10-21	Harris; Richard Y.	Method for treating multiple sclerosis
US5716808A (en)	1995-11-09	1998-02-10	Zymogenetics, Inc.	Genetic engineering of pichia methanolica
US5955349A (en)	1996-08-26	1999-09-21	Zymogenetics, Inc.	Compositions and methods for producing heterologous polypeptides in Pichia methanolica
US6025539A (en) *	1996-04-09	2000-02-15	Mayo Foundation For Medical Education And Research	IL-5 transgenic mouse
TW517067B (en) *	1996-05-31	2003-01-11	Hoffmann La Roche	Interferon conjugates
WO1998001553A2 (en) *	1996-07-09	1998-01-15	Genetics Institute, Inc.	Secreted proteins and polynucleotides encoding them
US5736383A (en)	1996-08-26	1998-04-07	Zymogenetics, Inc.	Preparation of Pichia methanolica auxotrophic mutants
US5854039A (en)	1996-07-17	1998-12-29	Zymogenetics, Inc.	Transformation of pichia methanolica
US5985614A (en)	1996-08-30	1999-11-16	Human Genome Sciences, Inc.	Polynucleotides encoding interleukin-19
EP1500329B1 (de)	1996-12-03	2012-03-21	Amgen Fremont Inc.	Menschliche Antikörper, die ausdrücklich menschliches TNF Alpha binden
GB9702944D0 (en) *	1997-02-13	1997-04-02	Univ Manchester	Reducing fibrosis
US5945511A (en)	1997-02-20	1999-08-31	Zymogenetics, Inc.	Class II cytokine receptor
US5965704A (en)	1997-08-05	1999-10-12	Zymogenetics, Inc.	Class two cytokine receptor-11
AU2871899A (en)	1998-03-09	1999-09-27	Schering Corporation	Human receptor proteins; related reagents and methods
EP1073730A1 (de) *	1998-04-17	2001-02-07	Whitehead For Biomedical Research	Verwendung von ribozym zum verbinden von nukleinsäuren mit polypeptiden
AR021876A1 (es) *	1998-12-18	2002-08-07	Schering Corp	Terapia de combinacion para vhc por induccion de ribavirina - interferon alfa pegilado
AU2158000A (en) *	1998-12-22	2000-07-12	Schering Corporation	Treatment of hepatitis c virus infections with interleukin-10
US6927040B2 (en) *	2000-06-30	2005-08-09	Zymogenetics, Inc.	Interferon-like protein Zcyto21
AU2002255478A1 (en) *	2001-01-10	2002-09-12	Pe Corporation (Ny)	Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
US7038032B2 (en)	2001-04-20	2006-05-02	Zymogenetics, Inc.	Cytokine protein family
JP2004535795A (ja)	2001-05-10	2004-12-02	イミュネックス・コーポレーション	サイトカインポリペプチド群
JP3939160B2 (ja) *	2001-05-25	2007-07-04	独立行政法人科学技術振興機構	腎臓における外来遺伝子発現方法
AU2003215136A1 (en)	2002-02-08	2003-09-02	University Of Medicine And Dentistry Of New Jersey	Ifn-a/b-independent mechanism of antiviral protection
EP1575609A4 (de)	2002-10-23	2010-12-15	Zymogenetics L L C	Verfahren zur behandlung von virusinfektionen unter verwendung von il-28 und il-29
WO2005023862A2 (en)	2003-08-07	2005-03-17	Zymogenetics, Inc.	Homogeneous preparations of il-28 and il-29
US20050244423A1 (en)	2004-04-02	2005-11-03	Klucher Kevin M	Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
JP4987001B2 (ja) *	2005-07-20	2012-07-25	ザイモジェネティクスリミテッドライアビリティカンパニー	癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法
AU2009255994B2 (en)	2008-06-05	2014-07-17	Bristol-Myers Squibb Company	Use of pegylated Type III Interferons for the treatment of hepatitis C
US20110263484A1 (en)	2008-10-13	2011-10-27	Zymogenetics, Inc.	Single chain fc type iii interferons and methods of using same

2001
- 2001-06-29 US US09/895,834 patent/US6927040B2/en not_active Expired - Lifetime
- 2001-06-29 BR BR0112119-7A patent/BR0112119A/pt active Search and Examination
- 2001-06-29 ES ES01950827T patent/ES2286128T3/es not_active Expired - Lifetime
- 2001-06-29 ES ES06012489T patent/ES2311253T3/es not_active Expired - Lifetime
- 2001-06-29 CN CNB018131530A patent/CN100448993C/zh not_active Ceased
- 2001-06-29 DE DE60135393T patent/DE60135393D1/de not_active Expired - Lifetime
- 2001-06-29 EP EP09172071A patent/EP2132984A3/de not_active Withdrawn
- 2001-06-29 DK DK06012489T patent/DK1717316T3/da active
- 2001-06-29 AU AU2001271786A patent/AU2001271786A1/en not_active Abandoned
- 2001-06-29 DK DK01950827T patent/DK1294888T3/da active
- 2001-06-29 WO PCT/US2001/021087 patent/WO2002002627A2/en not_active Ceased
- 2001-06-29 AT AT01950827T patent/ATE360696T1/de active
- 2001-06-29 DE DE60128093T patent/DE60128093T2/de not_active Expired - Lifetime
- 2001-06-29 JP JP2002507878A patent/JP4377126B2/ja not_active Expired - Lifetime
- 2001-06-29 EP EP06012489A patent/EP1717316B1/de not_active Expired - Lifetime
- 2001-06-29 AT AT06012489T patent/ATE404670T1/de active
- 2001-06-29 RU RU2003103099/13A patent/RU2292394C2/ru active
- 2001-06-29 CA CA2413258A patent/CA2413258C/en not_active Expired - Lifetime
- 2001-06-29 EP EP01950827A patent/EP1294888B1/de not_active Expired - Lifetime
- 2001-06-29 EP EP08100616A patent/EP1939293A3/de not_active Withdrawn
2004
- 2004-03-02 US US10/790,996 patent/US20040146988A1/en not_active Abandoned
- 2004-08-27 US US10/927,815 patent/US7253261B2/en not_active Expired - Lifetime
- 2004-08-27 US US10/928,539 patent/US7241870B2/en not_active Expired - Lifetime
- 2004-08-27 US US10/927,891 patent/US7252969B2/en not_active Expired - Lifetime
2006
- 2006-10-10 US US11/548,138 patent/US20070049736A1/en not_active Abandoned
- 2006-10-10 US US11/548,108 patent/US20070043209A1/en not_active Abandoned
- 2006-10-10 US US11/548,023 patent/US7445913B2/en not_active Expired - Lifetime
- 2006-10-10 US US11/548,056 patent/US7485700B2/en not_active Expired - Lifetime
2007
- 2007-10-16 US US11/873,272 patent/US7655223B2/en not_active Expired - Lifetime
- 2007-10-26 US US11/925,097 patent/US7498154B2/en not_active Expired - Lifetime
2008
- 2008-01-09 US US11/971,624 patent/US20080214788A1/en not_active Abandoned
- 2008-12-22 US US12/341,273 patent/US20090326204A1/en not_active Abandoned
2009
- 2009-11-30 US US12/628,078 patent/US7833520B2/en not_active Expired - Fee Related
2010
- 2010-09-30 US US12/895,139 patent/US7919595B2/en not_active Expired - Fee Related
2011
- 2011-03-02 US US13/039,223 patent/US20110172170A1/en not_active Abandoned
- 2011-09-08 US US13/227,548 patent/US20120036590A1/en not_active Abandoned
2012
- 2012-05-03 US US13/463,046 patent/US20120258458A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1717316B1 (de)	2008-08-13
US20090326204A1 (en)	2009-12-31
CN1443240A (zh)	2003-09-17
AU2001271786A1 (en)	2002-01-14
US20070049736A1 (en)	2007-03-01
CA2413258C (en)	2012-01-03
US20050106682A1 (en)	2005-05-19
US7833520B2 (en)	2010-11-16
US20050106680A1 (en)	2005-05-19
DK1717316T3 (da)	2008-12-08
US20110054148A1 (en)	2011-03-03
US20120036590A1 (en)	2012-02-09
ES2286128T3 (es)	2007-12-01
EP1939293A3 (de)	2008-07-09
DE60128093T2 (de)	2007-12-27
US20070043209A1 (en)	2007-02-22
US20080102490A1 (en)	2008-05-01
US20020039763A1 (en)	2002-04-04
US20070042468A1 (en)	2007-02-22
US20110172170A1 (en)	2011-07-14
EP2132984A3 (de)	2010-11-03
US7253261B2 (en)	2007-08-07
BR0112119A (pt)	2003-05-06
WO2002002627A3 (en)	2003-01-03
US7498154B2 (en)	2009-03-03
CN100448993C (zh)	2009-01-07
WO2002002627A2 (en)	2002-01-10
RU2003103099A (ru)	2005-01-20
ATE404670T1 (de)	2008-08-15
RU2292394C2 (ru)	2007-01-27
US20090069274A1 (en)	2009-03-12
US20040146988A1 (en)	2004-07-29
DE60128093D1 (de)	2007-06-06
US7485700B2 (en)	2009-02-03
DK1294888T3 (da)	2007-08-20
US7252969B2 (en)	2007-08-07
US7655223B2 (en)	2010-02-02
US20100222266A1 (en)	2010-09-02
EP1939293A2 (de)	2008-07-02
EP1294888B1 (de)	2007-04-25
ES2311253T3 (es)	2009-02-01
US7919595B2 (en)	2011-04-05
EP1294888A2 (de)	2003-03-26
US20120258458A1 (en)	2012-10-11
JP2004502419A (ja)	2004-01-29
EP2132984A2 (de)	2009-12-16
CA2413258A1 (en)	2002-01-10
US6927040B2 (en)	2005-08-09
EP1717316A1 (de)	2006-11-02
US20050014228A1 (en)	2005-01-20
US20070048841A1 (en)	2007-03-01
US7445913B2 (en)	2008-11-04
US7241870B2 (en)	2007-07-10
US20080214788A1 (en)	2008-09-04
ATE360696T1 (de)	2007-05-15
JP4377126B2 (ja)	2009-12-02

Publication	Publication Date	Title
ATE404670T1 (de)	2008-08-15	Allelische variante des interferon-ähnlichen proteins zcyto21
ATE388963T1 (de)	2008-03-15	Homogene herstellungen von il-29
DK0839196T3 (da)	2005-09-12	Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
ATE536406T1 (de)	2011-12-15	Neuartiger zytokin-zcytor17-ligand
DE69838143D1 (de)	2007-09-06	Antimikrobielle peptide
UA84666C2 (ru)	2008-11-25	ВЫДеЛЕНнЫЙ ПОЛИНУКЛЕОТИД, КОДИРУЮЩИЙ СЛИТОЙ ПРОТЕИН С ПЕСТИЦИДНОЙ АКТИВНОСТЬЮ, И ТРАНСГЕННАЯ КЛЕТКА-ХОЗЯИН
ATE403726T1 (de)	2008-08-15	Cytokin-proteinfamilie
ATE378408T1 (de)	2007-11-15	Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
ATE534742T1 (de)	2011-12-15	Polypeptide und nukleinsäuren von phorphorymonas gingivalis
DE69432427D1 (de)	2003-05-08	Tomate xyloglukan endotransglykosylase
AU2003264535A1 (en)	2004-04-19	Tumor antigen protein and utilization thereof
DE60225699D1 (de)	2008-04-30	Nierenspezifischer urattransporter und dessen gen
ATE216706T1 (de)	2002-05-15	Peptide des hiv-gag proteins, ihre herstellung und verwendung
DK0828004T3 (da)	2007-03-19	Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær
ATE432985T1 (de)	2009-06-15	Polypeptide mit aktivität der stimulierung von neutrophilen
ATE301199T1 (de)	2005-08-15	Beta-primeverosidase gen
WO1999060117A3 (fr)	2000-01-20	Polypeptide prax-1

Legal Events

Date	Code	Title	Description
2009-09-03	8364	No opposition during term of opposition